The story of Viagra and its effect on the drug landscape presents a thorny question for potential backers. Initially a hugely successful drug, copycat medications have significantly chipped away at its market https://owainlxnz242831.blogerus.com/63701255/the-blue-pill-and-big-pharma-a-risky-opportunity